Zelboraf ratings & reviews

Vemurafenib
Company: Genentech
Brand: Zelboraf
Drug class: Antineoplastic and Immunomodulating Agents
+2 more
Antineoplastic and Immunomodulating Agents, Antineoplastics, Small Molecule Antineoplastic RAF kinase Inhibitors
Overall rating
3.5
full star full star full star half star empty star
Ranked #1
Physician ratings
  • Efficacy: effective for its intended use
  • Safety: safe to use in humans
  • Tolerability: low drug side effects
  • Accessibility: insurance/payer coverage, cost, affordability,formulary coverage, availability in your hospital or practice setting
  • Adherence: patient compliance with treatment
Efficacy
3.6/5
Safety
3.4/5
Tolerability
3.4/5
Accessibility
3.3/5
Adherence
3.5/5

Sermo AI Overview

  • Zelboraf shows variable efficacy across indications, with scores around 3 to 4 out of 5. While it is effective for BRAF V600E mutated melanoma, physicians report mixed experiences and some patients face limitations, including side effects.
  • Patients treated with Zelboraf for Erdheim-Chester disease may respond differently, as noted by an average physician efficacy rating of 3.6 out of 5, suggesting a need for individualized treatment approaches.
  • While Zelboraf is a considered therapy for BRAF V600E mutated malignant melanoma, its best effects often require combination with a MEK inhibitor, indicating a need for careful treatment planning.
  • Some patients experience side effects with Zelboraf, including asthenia and transient responses, which highlights the importance of ongoing management and monitoring during treatment.
  • Was this summary helpful?
Based on insights from Sermo’s triple verified physicians

Description

Zelboraf contains vemurafenib, which is a kinase inhibitor. It is available as 240 mg tablets for oral administration. Key inactive ingredients include hypromellose acetate succinate, croscarmellose sodium, and magnesium stearate. Zelboraf is a medication commonly used to treat certain types of cancer, as it works by blocking a protein that helps cancer cells to grow.

Source: This information is sourced from FDA and powered by AI

Dosage & Administration

How should I use this medication?

Take this medication by mouth with a glass of water. Take it as directed on the prescription label. Do not cut, crush, or chew this medication. Swallow tablets whole. You can take it with or without food. If it upsets your stomach, take it with food. Keep taking it unless your care team tells you to stop.

A special MedGuide will be given to you by the pharmacist with each prescription and refill. Be sure to read this information carefully each time.

Talk to your care team about the use of this medication in children. Special care may be needed.

Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once.

NOTE: This medicine is only for you. Do not share this medicine with others.

What if I miss a dose?

If you miss a dose, take it as soon as you can. If it is less than 4 hours until your next scheduled dose, do not make up for the missed dose and just take your next dose at your regular time. Do not take double or extra doses.

Where should I keep my medication?

Keep out of the reach of children and pets.

Store at room temperature between 20 and 25 degrees C (68 and 77 degrees F). Keep this medication in the original container. Keep the container tightly closed. Get rid of any unused medication after the expiration date.

To get rid of medications that are no longer wanted or have expired:

  • Take the medication to a medication take-back program. Check with your pharmacy or law enforcement to find a location.
  • If you cannot return the medication, check the label or package insert to see if the medication should be thrown out in the garbage or flushed down the toilet. If you are not sure, ask your care team. If it is safe to put it in the trash, empty the medication out of the container. Mix the medication with cat litter, dirt, coffee grounds, or other unwanted substance. Seal the mixture in a bag or container. Put it in the trash.

NOTE: This sheet is a summary. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider.

Side Effects

What side effects may I notice from receiving this medication?

Side effects that you should report to your care team as soon as possible:

  • Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat
  • Eye pain, redness, irritation, or discharge with blurry or decreased vision
  • Heart rhythm changes—fast or irregular heartbeat, dizziness, feeling faint or lightheaded, chest pain, trouble breathing
  • Kidney injury—decrease in the amount of urine, swelling of the ankles, hands, or feet
  • Liver injury—right upper belly pain, loss of appetite, nausea, light-colored stool, dark yellow or brown urine, yellowing skin or eyes, unusual weakness or fatigue
  • Lump under the skin in the arch of the foot
  • Lump under the skin over hands, bent finger
  • Rash, fever, and swollen lymph nodes
  • Redness, blistering, peeling, or loosening of the skin, including inside the mouth

Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):

  • Fatigue
  • Hair loss
  • Itching
  • Joint pain
  • Nausea
  • Sensitivity to light

This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Warnings & Precautions

What should I tell my care team before I take this medication?

They need to know if you have any of these conditions:

  • Eye disease, vision problems
  • Heart disease
  • History of irregular heartbeat
  • History of low levels of calcium, magnesium, or potassium in the blood
  • Kidney disease
  • Liver disease
  • Recent or ongoing radiation therapy
  • An unusual or allergic reaction to vemurafenib, other medications, foods, dyes, or preservatives
  • Pregnant or trying to get pregnant
  • Breast-feeding

What may interact with this medication?

Do not take this medication with any of the following:

  • Cisapride
  • Dronedarone
  • Fluconazole
  • Pimozide
  • Posaconazole
  • Saquinavir
  • Thioridazine

This medication may also interact with the following:

  • Antiviral medications for HIV or AIDS
  • Caffeine
  • Certain antibiotics, such as clarithromycin, erythromycin, telithromycin
  • Certain medications for fungal infections, such as itraconazole, ketoconazole, voriconazole
  • Certain medications for irregular heart beat
  • Certain medications for seizures, such as carbamazepine, phenobarbital, phenytoin
  • Certain medications that treat or prevent blood clots, such as warfarin
  • Dextromethorphan
  • Digoxin
  • Nefazodone
  • Midazolam
  • Other medications that cause heart rhythm changes, such as dofetilide, ziprasidone
  • Rifabutin
  • Rifampin
  • Rifapentine
  • St. John's wort, Hypericum perforatum
  • Tizanidine

This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.

What should I watch for while using this medication?

Visit your care team for regular checks on your progress. You will need to have blood work while taking this medication.

This medication may cause serious skin reactions. They can happen weeks to months after starting the medication. Contact your care team right away if you notice fevers or flu-like symptoms with a rash. The rash may be red or purple and then turn into blisters or peeling of the skin. You might also notice a red rash with swelling of the face, lips, or lymph nodes in your neck or under your arms.

Talk to your care team about your risk of cancer. You may be more at risk for certain types of cancers if you take this medication.

Tell your care team right away if you have any change in your eyesight.

This medication can make you more sensitive to the sun. Keep out of the sun. If you cannot avoid being in the sun, wear protective clothing and use sunscreen. Do not use sun lamps or tanning beds/booths.

Talk to your care team if you wish to become pregnant or think you are pregnant. This medication can cause serious birth defects if taken during pregnancy and for 2 weeks after stopping therapy. Talk to your care team about effective forms of contraception. Do not breast-feed an infant while taking this medication and for 2 weeks after your last dose.

Source: This information is sourced from Elsevier Inc.

Disclaimer

The reviews, ratings, comments, and opinions expressed on this platform are solely those of the individual medical professionals who posted them and do not reflect the views or positions of Sermo, Inc. Sermo does not endorse, verify, or validate the content of individual reviews. The information provided is user-generated and reflects personal clinical experiences, which may not be complete, accurate, or applicable to your specific health needs. It is not intended as medical advice.

Prescription medications affect individuals differently, and what works for one person may not work for another. Always consult your doctor, pharmacist, or other qualified healthcare provider to ensure the information displayed applies to your personal circumstances. Only a licensed healthcare provider can advise you on what is safe and effective for you.

Keep all medications out of the reach of children, never share your medicine with others, and use each medication only as prescribed. Your reliance on any information provided on this platform is at your own risk.

Terms of use

  1. Sermo Drug Ratings, and all information provided on this website, may not be used in combination with any artificial intelligence tool (including to train an algorithm, test, process, analyze, generate output and/or develop any form of artificial intelligence tool). 

  2. Visitors to the online patient-facing website at Sermo.com (“Sermo Drug Ratings”) are Authorized Users of the website, which contains data owned by a third-party provider, Elsevier, Inc.  Accordingly, by visiting Sermo Drug Ratings, Authorized User acknowledges that the website includes Elsevier owned data that Sermo licenses pursuant to a separate usage and Data agreement (the “Agreements”).  Authorized User further acknowledges that Sermo is a third-party beneficiary of the Agreements and Authorized User’s use of the website hereby binds them to the terms of the Agreements; provided, however, that Elsevier shall have no obligations or liability to an Authorized User whatsoever pursuant to the terms of the Agreements.

  3. Authorized User acknowledges and agrees that the Elsevier Products are designed for and are intended to be used by those residing in the United States, and that the information contained in the Elsevier Products does not comply with any laws or practices outside of the United States. You assume all responsibilities, duties, and obligations for any treatment, decision, or advice made or given to third parties as a result of the use or application of the Elsevier Products outside of the United States, and Sermo, Elsevier and its affiliates, subsidiaries, agents and suppliers will incur no liability for any use or application of the Products by Authorized Users outside of the United States.

Welcome to Sermo's Drug Ratings

Previously only for members, Sermo Drug Ratings are now openly available to all healthcare providers, patients, and industry professionals to support better healthcare decisions.

Clinical expertise
Insights based on real prescribing experience from triple-verified practicing physicians only
Detailed insights
Ratings on key attributes including efficacy, safety, tolerability, accessibility, and adherence
Unbiased reviews
Independent, physician-only reviews, free from pharmaceutical industry influence